Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Hepatic failure in a patient taking rosiglitazone.

    Forman LM, Simmons DA, Diamond RH.

    Ann Intern Med. 2000 Jan 18;132(2):118-21.PMID: 10644272 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

    Lebovitz HE, Kreider M, Freed MI.

    Diabetes Care. 2002 May;25(5):815-21.PMID: 11978674 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hepatocellular injury in a patient receiving rosiglitazone. A case report.

    Al-Salman J, Arjomand H, Kemp DG, Mittal M.

    Ann Intern Med. 2000 Jan 18;132(2):121-4. Erratum in: Ann Intern Med 2000 Aug 1;133(3):237. PMID: 10644273 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hepatotoxicity with thiazolidinediones: is it a class effect?

    Scheen AJ.

    Drug Saf. 2001;24(12):873-88. Review.PMID: 11735645 [PubMed - indexed for MEDLINE]Related articles

    5.

    Troglitazone-induced hepatic failure leading to liver transplantation. A case report.

    Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, Brunt EM.

    Ann Intern Med. 1998 Jul 1;129(1):38-41.PMID: 9652998 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Thiazolidinediones and liver toxicity.

    Scheen AJ.

    Diabetes Metab. 2001 Jun;27(3):305-13. Review.PMID: 11431595 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

    Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B.

    Dig Dis Sci. 2002 Jul;47(7):1632-7.PMID: 12141828 [PubMed - indexed for MEDLINE]Related articles

    8.

    Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma.

    El-Naggar MH, Helmy A, Moawad M, Al-Omary M, Al-Kadhi Y, Habib B.

    Ann Pharmacother. 2008 May;42(5):713-8. Epub 2008 Apr 8.PMID: 18397974 [PubMed - indexed for MEDLINE]Related articles

    9.

    Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.

    May LD, Lefkowitch JH, Kram MT, Rubin DE.

    Ann Intern Med. 2002 Mar 19;136(6):449-52.PMID: 11900497 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.

    Murphy EJ, Davern TJ, Shakil AO, Shick L, Masharani U, Chow H, Freise C, Lee WM, Bass NM.

    Dig Dis Sci. 2000 Mar;45(3):549-53.PMID: 10749332 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rosiglitazone and hepatic failure.

    Freid J, Everitt D, Boscia J.

    Ann Intern Med. 2000 Jan 18;132(2):164. No abstract available. PMID: 10644281 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.

    Kohlroser J, Mathai J, Reichheld J, Banner BF, Bonkovsky HL.

    Am J Gastroenterol. 2000 Jan;95(1):272-6. Review.PMID: 10638596 [PubMed - indexed for MEDLINE]Related articles

    13.

    Second-generation thiazolidinediones and hepatotoxicity.

    Marcy TR, Britton ML, Blevins SM.

    Ann Pharmacother. 2004 Sep;38(9):1419-23. Epub 2004 Jul 20.PMID: 15266041 [PubMed - indexed for MEDLINE]Related articles

    14.

    Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination.

    Fukano M, Amano S, Sato J, Yamamoto K, Adachi H, Okabe H, Fujiyama Y, Bamba T.

    Hum Pathol. 2000 Feb;31(2):250-3.PMID: 10685643 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rosiglitazone.

    Goldstein BJ.

    Int J Clin Pract. 2000 Jun;54(5):333-7.PMID: 10954962 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.

    Cheng-Lai A, Levine A.

    Heart Dis. 2000 Jul-Aug;2(4):326-33. Review.PMID: 11728276 [PubMed - indexed for MEDLINE]Related articles

    17.

    Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

    Wagstaff AJ, Goa KL.

    Drugs. 2002;62(12):1805-37. Review.PMID: 12149047 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thiazolidinedione-associated congestive heart failure and pulmonary edema.

    Kermani A, Garg A.

    Mayo Clin Proc. 2003 Sep;78(9):1088-91.PMID: 12962163 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lessons from the glitazones: a story of drug development.

    Gale EA.

    Lancet. 2001 Jun 9;357(9271):1870-5. Review.PMID: 11410214 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pioglitazone-associated fulminant hepatic failure.

    Chase MP, Yarze JC.

    Am J Gastroenterol. 2002 Feb;97(2):502-3. No abstract available. PMID: 11866308 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data